HomeHealthcare & Life SciencesPharmaceuticals Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market

Brazil Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Size & Outlook, 2026-2034


Brazil Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Insights

  • As per Reed Intelligence insights, the Brazil Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market stood at USD 4.34 Million in 2025 and is anticipated to grow to USD 9.85 Million by 2034.
  • The Brazil market is expected to advance at a CAGR of 9.62% from 2026 through 2034.
  • In 2025, Drug Therapy accounted for the highest share of the Treatment Type market size.
  • During the forecast period, Supportive Therapy is set to register the highest growth, making it the most lucrative Treatment Type segment.

Other Key Findings


  • Brazil accounted for 2.35% of the global Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within LATAM, Brazil is forecasted to dominate the regional Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size by 2034.
  • Brazil will be the fastest-growing market in LATAM, projected to achieve USD 9.92 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 4.34 Million
Market Size In 2034 USD 9.85 Million
Largest segment Drug Therapy
Units Revenue in USD Million
CAGR 9.62% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Drug Therapy
  2. Gene Therapy
  3. Supportive Therapy
Route of Administration
  1. Oral
  2. Injectable
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Homecare Settings
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports